MARKET OUTLOOK
Triton Market Research predicts that the global market for cardiovascular ultrasound system would witness a CAGR of 5.31% over the forecast period 2019-2027.
Diseases related to the malfunctioning of the heart or blood vessels are called cardiovascular diseases. Cardiovascular disease or CVD is the biggest factor responsible for death worldwide. The most prominent causes of CVD are physical inactivity, unhealthy diet, tobacco use and harmful use of alcohol. Statistics from the W.H.O. indicate a 25% decline in deaths caused due to CVD and other non-communicable diseases; this decline can be attributed to the overall decrease in the usage of alcohol and tobacco, as well as advancements in cardiac surgery. The prevention and treatment of cardiovascular diseases are possible with the help of various medications.
Enhancements in technology, rising costs of healthcare, increase in the usage of minimally invasive procedures and an upswing in cases of cardiovascular diseases are driving the growth of the market globally. However, the escalating costs of surgeries, weak reimbursement policy and the increasing adoption of alternative technologies are factors responsible for restraining the cardiovascular ultrasound system market growth. The upsurge in R&D and the hastily rising demand for mobile-based ultrasound devices are great opportunities for market expansion. However, strict regulations by the government, complications of interventional cardiology devices and high costs of coronary stents and cardiac catheter-based treatments are challenging the growth of the market.
REGIONAL OUTLOOK
The global cardiovascular ultrasound system market covers five major regions worldwide, which include: Europe, North America, Asia-Pacific, Latin America and the Middle East and Africa.
The cardiovascular ultrasound system market in North America is the fastest-growing market globally, with the highest CAGR. The United States generates the highest revenue for the North America market. The US is one of the largest consumers of healthcare devices and equipment and spends huge capital on healthcare, which accounts for almost 17.9% of its GDP. It is predicted that one in every four death occurs due to heart diseases in the United States. The rising mortality due to cardiovascular diseases has increased the demand for the adoption of cardiac devices, such as cardiac ultrasound, echocardiogram, etc., which is contributing towards the growth of the United States cardiovascular ultrasound system market.
COMPETITIVE OUTLOOK
The companies that have been mentioned in the market report are Ultrasound Technologies Ltd., Stryker Corporation, Abbott Vascular, Inc., Philips Healthcare, Mindray Medical International Limited, Chison Medical Imaging Co., Ltd., Fujifilm Holdings Corporation, Toshiba Medical Systems Corporation (acquired by Canon, Inc.), Hitachi Medical Corporation, GE Healthcare, Inc., Boston Scientific Corporation, Esaote S.p.A., AtriCure, Inc., Unetixs Vascular, Inc. (acquired by Opto Circuits) and Samsung Electronics Co., Ltd.
GE Healthcare is a global medical devices and solutions company engaged in providing transformational medical technologies and services across the world. The company offers vital signs monitors, ultrasound systems, SenoBright Contrast Enhanced Spectral Mammography technology to detect breast cancer, wireless digital X-ray detectors, electronic medical record and practice management systems, and computed tomography systems. It also offers non-invasive solutions for imaging broken bones, trauma diagnosis, heart monitoring and identification of early-stage cancer. GE Healthcare recorded revenues of $18.3 billion in 2016. The company has its presence in North America, Asia-Pacific, Europe, Latin America and Africa.